Search

everythinglearnresearchcommunity

for

Search:↓

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Equilibrium dialysis can accurately measure testosterone levels when lab results are inconsistent.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Surgery on a 68-year-old woman with an ovarian tumor led to reduced hirsutism and normal testosterone levels.

A woman's excessive hair growth was caused by a rare benign tumor in her adrenal gland, which was successfully removed.

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Long-term testosterone treatment helps men with low testosterone levels lose weight.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

The normal human prostate does not significantly affect blood DHT levels.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

High testosterone levels can harm fertility by disrupting the LIF signaling pathway in the uterus.

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.